0001144204-12-025640.txt : 20120502
0001144204-12-025640.hdr.sgml : 20120502
20120502163805
ACCESSION NUMBER: 0001144204-12-025640
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120430
FILED AS OF DATE: 20120502
DATE AS OF CHANGE: 20120502
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCHUMACHER RICHARD T
CENTRAL INDEX KEY: 0001033775
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21615
FILM NUMBER: 12805774
MAIL ADDRESS:
STREET 1: 375 WEST STREET
CITY: WEST BRIDGEWATER
STATE: MA
ZIP: 02379
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PRESSURE BIOSCIENCES INC
CENTRAL INDEX KEY: 0000830656
STANDARD INDUSTRIAL CLASSIFICATION: MEASURING & CONTROLLING DEVICES, NEC [3829]
IRS NUMBER: 042652826
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 14 NORFOLK AVENUE
CITY: SOUTH EASTON
STATE: MA
ZIP: 02375
BUSINESS PHONE: 5082301828
MAIL ADDRESS:
STREET 1: 14 NORFOLK AVENUE
CITY: SOUTH EASTON
STATE: MA
ZIP: 02375
FORMER COMPANY:
FORMER CONFORMED NAME: BOSTON BIOMEDICA INC
DATE OF NAME CHANGE: 19960812
4
1
form450247_20120502043628-.xml
X0305
4
2012-04-30
0
0000830656
PRESSURE BIOSCIENCES INC
PBIO
0001033775
SCHUMACHER RICHARD T
130 LAKE RIDGE DRIVE
TAUNTON
MA
US 02780
1
1
0
0
CEO
Common Stock
2012-04-30
4
C
0
93786
0.8025
A
462152
D
Common Stock
2012-04-30
4
J
0
4652
0.8025
A
466804
D
Series C Convertible Preferred Stock
0.8025
2012-04-30
4
C
0
5018
D
2011-04-08
Common Stock
93786
0
D
Common Stock Purchase Warrant
2.38
2012-04-30
4
C
0
50180
D
2011-04-08
2014-04-08
Common Stock
50180
0
D
Common Stock Purchase Warrant
0.74
2012-04-30
4
C
0
46894
A
2012-04-05
2017-04-05
Common Stock
46894
46894
D
The Series C Convertible Preferred Stock has no expiration date.
Pursuant to a certain Securities Purchase Agreement, dated April 8, 2011, among the Company, the Reporting Person and the other purchasers named therein, the Reporting Person purchased 5,018 "Units" at a purchase price of $15.00 per Unit. Each Unit consisted of (i) one share of Series C Convertible Preferred Stock convertible into 10 shares of common stock and (ii) a warrant to purchase one share of Common Stock, which warrant is exercisable until April 8, 2014. The Reporting Person exchanged these securities for 93,786 shares of the company's common stock with a value of $0.8025 per share and warrants to purchase 46,894 shares of the company's common stock at an exercise price of $0.74 per share.
The shares acquired are the result of a 5% stock dividend on Pressure BioSciences, Inc. Series C Convertible Preferred Stock.
Richard T Schumacher
2012-05-02